Mr. Damien McCallion:

That is fine. We hope to have close out the timeframes over the next month. There are a number of elements. We have identified the capacity and we are working through the contractual element now. We are also working on the pre-inspection aspect. We are trying to gather information to ensure the laboratories meet the quality standards. As Dr. Doherty stated earlier, quality assurance visits will follow. That is the sort of timescale we are looking at. We have worked up all the options and we have been constantly looking at them.

There is, however, a downside to temporary suspension because we would simply be moving the problem. We would alleviate something now but we would also create another problem that we may or may not have capacity for to solve later. We have looked at variations regarding time periods but our focus in the next month will be to try to nail down the capacity we have identified and get it into place. That will, hopefully, help to alleviate the backlog. Two of the laboratories have managed to do that. We now need to do it for the third. It is working closely with us to identify capacity.